CrushSCI.com
126.3Average days
77Median days
13Fastest days
357Longest days
4872025 publications

Paper Review Records

All Paper Review Records

30 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.

52 days

Risk of Upper Limb Tendinopathy and Tenosynovitis Comparison Between Glucagon Like Peptide‐1 Receptor Agonists and Sodium‐Glucose Cotransporter 2 Inhibitors

Authors
Pei‐Yun Chen; Sunny Ssu‐Yu Chen; Renin Chang; Mei‐Chia Chou; Pili Chih‐Min MaoShow moreShow less
Affiliations
1. Department of Physical Medicine and Rehabilitation Kaohsiung Armed Forces General Hospital Kaohsiung Taiwan; 2. School of Medicine, National Defense Medical University Taipei Taiwan; 3. Department of Physical Medicine and Rehabilitation Kaohsiung Veterans General Hospital Kaohsiung Taiwan; 4. School of Medicine, Chung Shan Medical University Taichung Taiwan; 5. Institute of Neuroscience National Yang Ming Chiao Tung University Taipei Taiwan; 6. Department of Medical Education and Research Kaohsiung Veterans General Hospital Kaohsiung Taiwan; 7. Department of Emergency Medicine Kaohsiung Veterans General Hospital Kaohsiung Taiwan; 8. Department of Recreation and Sports Management Tajen University Pingtung Taiwan; 9. Department of Physical Medicine and Rehabilitation Pingtung Veterans General Hospital Pingtung Taiwan; 10. Department of Physical Medicine and Rehabilitation Pingtung Veterans General Hospital, Longquan Branch Pingtung Taiwan; 11. Department of Nursing Meiho University Pingtung Taiwan; 12. Department of Pharmacy Kaohsiung Veterans General Hospital Kaohsiung Taiwan; 13. School of Pharmacy National Defense Medical Center Taipei TaiwanShow moreShow less
Source PDF DOI Publisher page
13 days

Association of Metabolic Syndrome and Its Components With Functional Status in Patients With Knee Osteoarthritis

Authors
Zahra Kamiab; Gholamreza Bazmandegan; Zahra Khezri‐moghadam; Mitra AbbasifardShow moreShow less
Affiliations
1. Department of Community Medicine, School of Medicine Rafsanjan University of Medical Sciences Rafsanjan Iran; 2. Physiology‐Pharmacology Research Center, Research Institute of Basic Medical Sciences Rafsanjan University of Medical Sciences Rafsanjan Iran; 3. Department of Physiology and Pharmacology, School of Medicine Rafsanjan University of Medical Sciences Rafsanjan Iran; 4. Clinical Research Development Unit, Ali‐Ibn Abi‐Talib Hospital Rafsanjan University of Medical Sciences Rafsanjan Iran; 5. Department of Internal Medicine, School of Medicine, Ali‐Ibn Abi‐Talib Hospital Rafsanjan University of Medical Sciences Rafsanjan IranShow moreShow less
Source PDF DOI Publisher page
18 days

Very Low‐Dose Glucocorticoids in Inflammatory Rheumatic Diseases: Mechanisms, Evidence, and Unanswered Questions

Authors
I‐Han Cheng; Andriko Palmowski; Edgar WiebeShow moreShow less
Affiliations
1. Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences University of Oxford Oxford UK; 2. Department of Rheumatology and Clinical Immunology Charité – Universitätsmedizin Berlin Berlin Germany; 3. Section for Biostatistics and Evidence‐Based Research, the Parker Institute, Bispebjerg and Frederiksberg Hospital University of Copenhagen Copenhagen Denmark; 4. Epidemiology and Health Services Research German Rheumatism Research Center (DRFZ), a Leibniz Institute Berlin Germany; 5. Berlin Institute of Health (BIH), Charité – Universitätsmedizin Berlin Berlin GermanyShow moreShow less
Source PDF DOI Publisher page
23 days

Isolated Pre‐Septal Orbital Mass and Ptosis: An Uncommon Presentation of Sarcoidosis

Authors
Deepak Moka; Bhargavi Pridhivi; Venkat Shashidhar Chittapragada; Sanjay Jain; Varun DhirShow moreShow less
Affiliations
1. Division of Clinical Immunology and Rheumatology, Department of Internal Medicine Postgraduate Institute of Medical Education and Research Chandigarh India; 2. Department of Histopathology Postgraduate Institute of Medical Education and Research Chandigarh IndiaShow moreShow less
Source PDF DOI Publisher page
335 days

Therapeutic Advances and Clinical Perspectives of IL ‐1 Target Therapy in Autoinflammatory Disease

Authors
Chufan Qu; Meiping LuShow moreShow less
Affiliations
1. Department of Rheumatology Immunology & Allergy Children's Hospital, Zhejiang University School of Medicine Hangzhou ChinaShow moreShow less
Source PDF DOI Publisher page
104 days

Anakinra for the Treatment of Severe Still's Disease Complicated With Macrophage Activation Syndrome

Authors
Jiaxian Guo; Haojie Xu; Weiwei Li; Ying Wang; Yi Zhang; Yuan Jia; Yuan An; Huaqun ZhuShow moreShow less
Affiliations
1. Department of Rheumatology and Immunology Peking University People's Hospital Beijing China; 2. Beijing Key Laboratory of Non‐Invasive Diagnosis and Immunotherapy of Rheumatic Diseases Beijing China; 3. Department of Rheumatology and Immunology Dongying Hospital of Traditional Chinese Medicine Dongying Shandong China; 4. Department of Rheumatology and Immunology The Fifth Hospital of Xiamen Xiamen Fujian China; 5. Department of Rheumatology and Immunology The Second Affiliated Hospital of Xiamen Medical College Xiamen Fujian ChinaShow moreShow less
Source PDF DOI Publisher page

FAQ

How long does International Journal of Rheumatic Diseases take to review a manuscript?

As of 2026-11-18, CrushSCI has 30 complete review records for International Journal of Rheumatic Diseases. The fastest paper went from submission to acceptance in 13 days (Association of Metabolic Syndrome and Its Components With Functional Status in Patients With Knee Osteoarthritis, received 2026-09-28, accepted 2026-10-11); the slowest took 357 days. The average is 126.3 days and the median is 77 days.

Expert Matching · Case Demo

Turn Your Submission Goalsinto a Verifiable Journal Plan

Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.

We will reply within 30 minutes.

CrushSCI online

Client

I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?

CrushSCI

Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.

Suggested title
Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment

SampleLatest 5 valid paper samples from 2026

Average review59.6 days

Median65 days

Contact CrushSCI

Contact CrushSCI

Leave your email address to discuss academic polishing, structural refinement, or one-to-one guidance.

We will reply within 30 minutes.

Selected service: Academic Consulting Service

Leave your email address

Or email us directly at leader@crushsci.com

Enter your email address so we can reply. Your details will remain private.